About this page

Our systems have detected unusual traffic from your computer network. This page checks to see if it's really you sending the requests, and not a robot. Why did this happen?

IP address: 3.80.24.244
Time: 2024-03-29T14:53:32Z
URL: http://scholar.google.com/scholar_lookup?title=Phase+II+trial+of+the+anti-CD19+bispecific+T+cell-engager+blinatumomab+shows+hematologic+and+molecular+remissions+in+patients+with+relapsed+or+refractory+B-precursor+acute+lymphoblastic+leukemia&year=2014&author=Topp&journal=J+Clin+Oncol&volume=32&issue=36&pages=4134-4140&doi=10.1200%2FJCO.2014.56.3247&pmid=25385737